###begin article-title 0
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
Identification of MAMDC1 as a Candidate Susceptibility Gene for Systemic Lupus Erythematosus (SLE)
###end article-title 0
###begin p 1
Conceived and designed the experiments: AH CML MD JK. Performed the experiments: AH TMJ GA LB VVM. Analyzed the data: AH MZ CML PO JP ARS TH KK. Contributed reagents/materials/analysis tools: CML USK TMJ SK HJ TS EW IG ES LP AW DSCG TJV JK. Wrote the paper: AH CML MD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with multiple susceptibility genes. We have previously reported suggestive linkage to the chromosomal region 14q21-q23 in Finnish SLE families.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
Genetic fine mapping of this region in the same family material, together with a large collection of parent affected trios from UK and two independent case-control cohorts from Finland and Sweden, indicated that a novel uncharacterized gene, MAMDC1 (MAM domain containing glycosylphosphatidylinositol anchor 2, also known as MDGA2, MIM 611128), represents a putative susceptibility gene for SLE. In a combined analysis of the whole dataset, significant evidence of association was detected for the MAMDC1 intronic single nucleotide polymorphisms (SNP) rs961616 (P -value = 0.001, Odds Ratio (OR) = 1.292, 95% CI 1.103-1.513) and rs2297926 (P -value = 0.003, OR = 1.349, 95% CI 1.109-1.640). By Northern blot, real-time PCR (qRT-PCR) and immunohistochemical (IHC) analyses, we show that MAMDC1 is expressed in several tissues and cell types, and that the corresponding mRNA is up-regulated by the pro-inflammatory cytokines tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) in THP-1 monocytes. Based on its homology to known proteins with similar structure, MAMDC1 appears to be a novel member of the adhesion molecules of the immunoglobulin superfamily (IgCAM), which is involved in cell adhesion, migration, and recruitment to inflammatory sites. Remarkably, some IgCAMs have been shown to interact with ITGAM, the product of another SLE susceptibility gene recently discovered in two independent genome wide association (GWA) scans.
###end p 5
###begin title 6
Significance
###end title 6
###begin p 7
Further studies focused on MAMDC1 and other molecules involved in these pathways might thus provide new insight into the pathogenesis of SLE.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 114 117 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Danchenko1">[1]</xref>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Deapen1">[2]</xref>
###xml 537 540 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Hochberg1">[4]</xref>
###xml 750 753 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Tsao1">[5]</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Criswell1">[10]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Lee1">[11]</xref>
###xml 1093 1096 1093 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Tsao1">[5]</xref>
###xml 1097 1100 1097 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Moser1">[9]</xref>
###xml 1288 1292 1288 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Harley3">[12]</xref>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Kozyrev1">[15]</xref>
SLE (MIM152700) is a multisystemic autoimmune disorder, with varying incidence and prevalence between populations [1]. The disease is characterized by autoantibody production against self, formation of immune complexes, and subsequent tissue inflammation in multiple organs such as the skin, joints, kidneys and heart. Although the underlying pathogenic mechanisms of SLE remain imperfectly understood, both environmental influences and genetic factors have been found to play an important role in disease initiation and progression [2]-[4]. Supporting a genetic component in SLE, genome-wide linkage scans have identified several loci showing significant linkage to the disease, some of which have been confirmed in independent studies (reviewed in [5]-[10]). In particular, the importance of the two chromosomal regions 6p22.3-p21.1 (HLA region) and 16p12.3-q12.2 has been highlighted in a meta-analysis of genome wide linkage studies in SLE [11]. In addition to these loci, a large number of genes and genetic effects have been associated to SLE through candidate gene studies (reviewed in [5]-[9]). Recent GWA studies have further provided new fundamental insight into the genetics of SLE by identifying new susceptibility genes and consolidating results obtained in previous studies [12]-[15].
###end p 9
###begin p 10
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 693 694 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Gaffney1">[18]</xref>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Shai1">[19]</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Zhou1">[20]</xref>
Our group previously reported suggestive linkage on chromosomes 5p (Nonparametric linkage (NPL) score = 2.03, P-value = 0.02), 6q25-q27 (NPL score = 2.47, P-value = 0.008), 14q21-q23 (NPL score = 2.20, P-value = 0.02) as well as the HLA region (NPL score = 2.17, P-value = 0.02) in a genome-wide scan of 35 Finnish multiplex families [16]. Following up the loci on chromosome 6q and 14q, with an additional 31 Finnish simplex families included in the cohort, we identified sharing of two common haplotypes on chromosome 14q21-23 (spanning markers D14S978-D14S589-D14S562 and D14S1009-D14S748, P-value = 0.006 and 0.14 respectively), and excess transmission of a haplotype (GATA184A08-D6S1637, P-value = 0.07) on 6q [17]. The chromosome 14 region had previously been reported as a suggestive SLE susceptibility locus in two other independent studies [18], [19] as well as in Systemic Sclerosis (MIM 181750) [20], and was thus subsequently considered of particular interest for gene identification.
###end p 10
###begin p 11
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
In the present study, we have taken a hierarchical, multistep approach to delineate the SLE susceptibility locus contained within the chromosome 14q21-14q23 region and identified a gene, MAMDC1, as a novel candidate gene for SLE.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
###xml 323 331 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g001">Figure 1</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008037.s001">Table S1</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Dudbridge1">[21]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Toivonen1">[22]</xref>
###xml 854 862 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g001">Figure 1</xref>
###xml 1047 1053 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
The original Finnish cohort, with an additional 126 families, was used in the initial fine mapping, which focused on the two regions showing haplotype sharing in the previous fine-mapping [16], [17]. This step of genotyping included 19 microsatellite (MS) markers and 17 SNPs, located within a region spanning 14q11.2-q23 (Figure 1 and Table S1). Together with the MS markers already analyzed in our previous studies [16], [17] genotyping data were thus available in this initial step for 47 MS markers and 17 SNPs, corresponding to an average marker distance of 350 kilo bases (kb) in the region. To increase the chances of identifying SLE susceptibility loci in this region, two different statistical analyses were performed on genotyped data; Pedigree Disequilibrium Test (PDT) [21] and Haplotype Pattern Mining (HPM) [22]. As graphically reported in Figure 1, only one region provided positive signals of association with both methods, namely the 800 kb sequence contained between markers D14S1068 and rs1955810. The poorly characterized gene MAMDC1 maps right in the middle of and are entirely contained within this region. We therefore focused our downstream analysis onto this locus.
###end p 13
###begin title 14
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
Identification of MAMDC1 as the SLE susceptibility locus in the 14q21-q23 linkage region.
###end title 14
###begin p 15
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
###xml 489 495 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 841 842 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 886 906 884 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
Fine mapping towards the identification of MAMDC1 was first performed in the original Finnish family cohort by genotyping 19 MS markers and 17 SNPs, focusing on the two regions located on 14q11.2-q23 that showed haplotype sharing in the previous fine-mapping [16], [17]. PDT and HPM analyses were used and regions providing significant results (p</=0.05) are shown in black and blue, respectively (top of the figure). The region between markers D14S1068 and rs1955810, containing the gene MAMDC1, was selected for further fine mapping (highlighted in blue). Twenty-four SNPs were subsequently genotyped in the whole sample material and as shown graphically in the figure, significant association for the SNPs rs961616 and rs2297926 could be identified using a combined analysis (bottom of the figure). The significance threshold were set to P = 0.0032 (see the statistics section under material and methods) and is represented by a red line.
###end p 15
###begin p 16
###xml 348 368 348 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and methods</xref>
###xml 373 381 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008037.s001">Table S1</xref>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 587 595 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g001">Figure 1</xref>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008037.s001">Table S1</xref>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 783 784 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 944 945 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 997 1005 997 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g001">Figure 1</xref>
###xml 1036 1044 1036 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008037.s002">Table S2</xref>
To further explore the observed association, three additional SLE cohorts were included in the study; one family cohort from the UK consisting of 365 SLE parent affected trios, one case control cohort from Finland consisting of 86 SLE cases and 356 controls and one case control cohort from Sweden consisting of 304 SLE cases and 307 controls (see Material and methods and Table S1). Twenty four SNPs, spanning the MAMDC1 gene, were thus subsequently genotyped in all four sample populations to obtain information regarding the genetic contribution of MAMDC1 in the European population (Figure 1 and Table S1). A combined analysis, including all four populations, revealed that two SNPs at the MAMDC1 locus; rs961616 (P -value = 0.001, OR = 1.292, 95% CI 1.103-1.513) and rs2297926 (P - value = 0.003, OR = 1.349, 95% CI 1.109-1.640) significantly contribute to SLE susceptibility after correction for multiple testing. A graphical view of the P - value distribution of the 24 markers is shown in Figure 1 and exact values are shown in Table S2. Haplotype analysis was also performed for each sample population but this did not add any further information.
###end p 16
###begin p 17
###xml 228 236 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g002">Figure 2</xref>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
Despite some individual differences between the study populations, no significant findings were obtained by heterogeneity testing, and the pooled ORs for rs961616 and rs2297926 both remained above the threshold of significance (Figure 2), thus suggesting MAMDC1 as a candidate gene in SLE susceptibility.
###end p 17
###begin title 18
Individual and pooled odds ratios for rs961616 and rs2297926.
###end title 18
###begin p 19
The individual and pooled contribution of each sample population for rs961616 (A) and rs2297926 (B), shown as ORs.
###end p 19
###begin p 20
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 317 326 317 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g003">Figure 3A</xref>
###xml 399 408 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g003">Figure 3B</xref>
###xml 717 726 717 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g003">Figure 3B</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Zdobnov1">[23]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Eisenhaber1">[24]</xref>
###xml 1166 1170 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Bendtsen1">[25]</xref>
###xml 1265 1269 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-DiazLopez1">[26]</xref>
###xml 1271 1275 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-DeJuan1">[27]</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Litwack1">[28]</xref>
###xml 1648 1652 1648 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Walsh1">[29]</xref>
###xml 1787 1795 1787 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g004">Figure 4</xref>
###xml 581 591 <span type="species:ncbi:9598">chimpanzee</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 600 603 <span type="species:ncbi:10116">rat</span>
###xml 605 608 <span type="species:ncbi:9615">dog</span>
###xml 613 618 <span type="species:ncbi:9796">horse</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 1232 1237 <span type="species:ncbi:9606">human</span>
###xml 1287 1290 <span type="species:ncbi:10116">rat</span>
MAMDC1 is a poorly characterized gene spanning 835 kb of DNA sequence on the reverse strand of Chromosome 14q21.3, and predicted to be composed of two alternative first exons (1a and 1b) and 16 downstream exons giving rise to two mRNAs of similar size (5375 bp for isoform 1, and 5239 bp for isoform 2, respectively; Figure 3A). These correspond to MAMDC1 full-length protein (956 amino acids [aa], Figure 3B) and a shorter peptide where translation is predicted to start at an internal ATG codon from exon 7 (727 aa, not shown). Strikingly, the former shows >97% aa identity with chimpanzee, mouse, rat, dog and horse MAMDC1 orthologs, suggesting an important function for this highly conserved protein. As shown in Figure 3B, analysis of human MAMDC1 full length amino acid sequence with the protein prediction tool InterPro Scan [23] revealed the presence of 6 immunoglobulin (Ig) like domains, a fibronectin type III like (FNIII) fold domain, and a meprin/A5-protein/PTPmu (MAM) domain in the corresponding polypeptide chain. In addition, a C-terminal GPI anchoring signal was detected using big-PI Predictor [24], and an N-terminal signal sequence with SignalP [25]. Interestingly, identical domain structures are found in the human homolog MDGA1 (MIM 609626) [26], [27] and in the rat orthologs MDGA1 and MDGA2 previously identified in different neuronal populations [28]. Based on their protein architecture and pattern of expression, MDGA proteins have been proposed as a novel subgroup of the IgCAM super family, an important class of membrane proteins involved in cell-cell adhesion, migration and the development of neuronal connections [29]. An alignment of MAMDC1 with these and other proteins sharing similar domains and suggested to have a role in adhesion is reported in Figure 4.
###end p 20
###begin title 21
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human MAMDC1 gene, mRNA and protein structure.
###end title 21
###begin p 22
###xml 3 9 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
A) MAMDC1 genomic structure and exon-intron organization. Exons are reported as plain boxes with relative length (in bp) below. Intronic intervening sequences are also shown with relative length (in kb) above. Two alternative MAMDC1 mRNA isoforms are predicted to be transcribed from the MAMDC1 locus, corresponding to NCBI database entries NM_001113498 and NM_182830. Translation initiation codons (ATG) are indicated for both isoforms. B) Schematic representation of MAMDC1 predicted full-length protein (corresponding to mRNA isoform 1), and its structural domains with relative length (amino acid positions) below.
###end p 22
###begin title 23
###xml 30 35 <span type="species:ncbi:9606">human</span>
Comparison of homologs of the human MAMDC1 protein.
###end title 23
###begin p 24
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Chenna1">[60]</xref>
Alignment of MAMDC1 full-length polypeptide with other proteins containing identical structural domains (reported on the left: MAM, meprin/A5-protein/PTPmu; FNIII, fibronectin, type III-like fold, Ig-like, immunoglobulin-like; EGF, epidermal growth factor; MATH/TRAF, meprin and TRAF-C homology/TNF-receptor associated factor; FV/FVIII, coagulation factor V/VIII; CUB, complement C1r/C1s, Uegf, Bmp1). The branching diagram (cladogram) was generated by multiple sequence alignment of the protein sequences using ClustalW [60].
###end p 24
###begin p 25
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g005">Figure 5</xref>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 831 837 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Litwack1">[28]</xref>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 883 886 <span type="species:ncbi:10116">rat</span>
In order to initially characterize MAMDC1 distribution in different tissues and cells, we sought to analyze its mRNA and protein expression patterns, respectively by Northern blot hybridization and IHC experiments. As shown in Figure 5, a weak signal corresponding to the expected MAMDC1 mRNA size of 5 kb was seen in all tissues except urinary bladder and uterus after hybridization of the full-length cDNA probe (corresponding to MAMDC1 isoform 1) on two human multiple tissue polyA+ RNA Northern blots. Several additional transcripts of smaller size were also present in tissues such as the brain, heart, pancreas and others, while a band of approximately 9 kb was further seen in brain, placenta and thyroid, thus suggesting that MAMDC1 primary transcript undergoes alternative splicing. Hence, our results indicate that human MAMDC1 has a much broader expression than its MDGA2 rat ortholog [28], as it is found at a low level in a wide range of tissues outside the nervous system.
###end p 25
###begin title 26
Analysis of MAMDC1 mRNA expression.
###end title 26
###begin p 27
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Northern blot analysis of MAMDC1 mRNA expression in different human tissues, showing several expressed splice variants. MAMDC1 mRNA transcript corresponding to the full-length isoform is indicated by an arrowhead on the right side. A beta-Actin cDNA control probe was used for normalization (bottom).
###end p 27
###begin p 28
###xml 300 308 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g006">Figure 6</xref>
###xml 465 486 465 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g006">Figures 6A, 6C and 6D</xref>
###xml 603 620 603 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g006">Figures 6E and 6I</xref>
###xml 740 757 740 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g006">Figures 6G and 6H</xref>
###xml 230 236 <span type="species:ncbi:9986">rabbit</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
To confirm and extend these results, we then studied MAMDC1 protein expression by IHC on formalin-fixed paraffin-embedded tissue sections from testis, kidney, duodenum, placenta, cutaneous squamous cell carcinoma, and SLE skin. A rabbit anti-MAMDC1 antibody was used for this purpose and as shown in Figure 6, MAMDC1 protein expression could be detected in Leydig cells of the testis, in placental syncytial trophoblasts and epithelial cells of the duodenal villi (Figures 6A, 6C and 6D respectively). Further, both kidney and cutaneous squamous cell carcinomas showed positive staining in neutrophils (Figures 6E and 6I). In skin samples obtained from SLE patients the protein was detected in elastic fibres in the upper layers of dermis (Figures 6G and 6H). The results obtained with IHC are in accordance with the data obtained from the analysis of mRNA expression, and further support the finding that MAMDC1 is expressed in tissues other than the nervous system.
###end p 28
###begin title 29
Analysis of MAMDC1 protein expression.
###end title 29
###begin p 30
IHC analysis of MAMDC1 protein expression in A) testis, showing positive staining in Leydig cells; B) testis, negative control; C) placenta, showing positive staining in syncytial trophoblasts (arrows); D) positive duodenal villi; E) kidney, positive staining observed in occasional glomerular neutrophils; F) kidney, negative control; G) SLE skin with positive staining in the upper dermis in the same region as elastic fibres; H) SLE skin stained with Weigert's Resorcin-Fuchsin, detecting elastic fibers: arrows in G and H mark corresponding regions I) Cutaneous squamous cell cancer, with positive staining in neutrophils. Scale bars: 5 microm (A, B, G, H), 2.5 microm (C, D, I), 1.6 microm (E, F).
###end p 30
###begin p 31
###xml 164 172 164 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 896 902 896 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 1082 1086 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Aringer1">[30]</xref>
###xml 1087 1091 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Theofilopoulos1">[32]</xref>
###xml 1546 1552 1532 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 1693 1701 1671 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008037-g007">Figure 7</xref>
###xml 1913 1917 1891 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Ohmori1">[33]</xref>
We next sought to determine whether such expression shows conditional regulation, and tested the effect of pro- and anti-inflammatory stimuli on gene transcription in vitro. The cell lines THP-1 (monocytic leukemia), A431 (epidermoid carcinoma), A549 (lung epithelial carcinoma), HeLa (cervix epithelial adenocarcinoma), SH-Sy5y (neuroblastoma), MCF7 (breast adenocarcinoma), HCT116 (colon carcinoma) and HEK293 (embryonic kidney cells) were first tested for MAMDC1 mRNA expression in a quantitative qRT-PCR assay specific for the full-length isoform 1. In these experiments, moderate levels of MAMDC1 could be detected in THP-1 and MCF7 cells, while all other cell-lines showed little or no mRNA expression (data not shown). Monocytes play a key role in inflammation and immunological diseases, and therefore we selected the THP-1 monocytic cells for the next experiments. The effect exerted on MAMDC1 mRNA expression by TNF-alpha, IFN-gamma and interleukin 1 beta (IL-1beta), three cytokines playing a pivotal role in inflammation and in chronic inflammatory diseases such as SLE [30]-[32], by lipopolysaccharide (LPS), a potent endotoxin activating macrophage pro-inflammatory responses, and by transforming growth factor beta 1 (TGF-beta1), an anti-inflammatory cytokine with pleiotropic effects in SLE and other autoimmune disorders, was then determined by qRT-PCR on THP-1 cells at 6 h and 24 h after the addition of these molecules to the culture medium. While no differences were observed 6 h post stimulation (not shown), an increase in MAMDC1 mRNA levels was observed 24 h after the addition of either TNF-alpha or IFN-gamma to THP-1 cells (2.5 and 2.4 fold induction, respectively, Figure 7). Of note, such increase was dramatically pronounced under the combined stimulus of these two cytokines (63 fold induction), possibly due to their known synergistic pro-inflammatory effect on gene transcription [33].
###end p 31
###begin title 32
Effect of selected cytokines on MAMDC1 mRNA expression in THP-1 monocytes.
###end title 32
###begin p 33
THP-1 cells were treated for 24 h with LPS, TGF-beta1, IL-1beta, IFN-gamma, TNF-alpha, or a combination of TNF-alpha and IFN-gamma, and MAMDC1 mRNA expression was quantified by Real-Time PCR in triplicate experiments. The results are reported as fold changes relative to THP-1 cells grown in the absence of stimulation (control), with the smallest observation, lower quartile, median, upper quartile, and largest observation shown for each sample.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
In the present study, we have identified association between SNPs in the novel gene MAMDC1 and SLE in four independent samples from Finland, Sweden and the UK.
###end p 35
###begin p 36
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
There are 2317 SNPs contained within MAMDC1, which covers a region of 0.8 megabases (Mb) and several linkage disequilibrium (LD) blocks (not shown). Based on the moderate effect of MAMDC1 on SLE susceptibility, it is unlikely that this gene would appear among the top findings reported in any of the GWAs studies.
###end p 36
###begin p 37
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-vandenOord1">[34]</xref>
###xml 149 155 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 247 249 247 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Hettema1">[35]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Costa1">[36]</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Brandes1">[37]</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Widiger1">[38]</xref>
###xml 808 814 808 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Bucan1">[39]</xref>
###xml 969 975 969 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
Recently, MAMDC1 was also found associated with neuroticism in a GWA study followed by a replication in an independent sample set [34]. Four SNPs in MAMDC1, all located in a 3' 37 kb region of high LD including the 10th exon, showed P-values of 10-6 to 10-5 in the GWA study sample and of 0.006 to 0.02 in the replication sample. However, this finding could not be supported in a follow-up association study [35]. Neuroticism is a trait that reflects a tendency toward negative mood states [36] and is linked to internalizing psychiatric conditions, such as anxiety and depression [37], [38]. With regard to SLE, this finding is of relevance since neuropsychiatric manifestations are among the ACR criteria used in the diagnosis of SLE. Furthermore, and of potential interest, exonic copy number variants in MAMDC1 was recently shown to contribute to risk in autism spectrum disorders [39]. Unfortunately we do not have sufficient power to test for association between MAMDC1 and different SLE neuropsychiatric manifestations.
###end p 37
###begin p 38
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Litwack1">[28]</xref>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 364 370 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Pallis1">[40]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Belmont1">[43]</xref>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 115 118 <span type="species:ncbi:10116">rat</span>
###xml 300 306 <span type="species:ncbi:9606">humans</span>
The expression and function of the MAMDC1 gene and protein are not well studied: besides showing expression in the rat brain and suggested to have a role in axon guidance [28], not much is known. We report here for the first time that the MAMDC1 gene and protein were expressed in several tissues in humans, including the immune system. We could further show that MAMDC1 mRNA is up-regulated by pro-inflammatory cytokines. Similar to previous observations made for other members of the IgCAM superfamily, such as intercellular adhesion molecule-1 (ICAM-1 [MIM 147840]) and vascular cell adhesion molecule-1 (VCAM-1 [MIM 192225]) [40]-[43], these results suggest that MAMDC1 expression could increase during inflammation, and it is tempting to speculate that its potential role in SLE might be related to the dysregulation of immune functions typical of this disease.
###end p 38
###begin p 39
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Norman1">[44]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-McMurray1">[45]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Sfikakis1">[46]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Belmont1">[43]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Pallis1">[40]</xref>
###xml 884 888 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Svenungsson1">[47]</xref>
###xml 1221 1226 1217 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAM</italic>
###xml 1289 1293 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Harley3">[12]</xref>
###xml 1295 1299 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Hom1">[13]</xref>
###xml 1441 1445 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Dunne1">[48]</xref>
###xml 1493 1499 1489 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 1504 1509 1500 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAM</italic>
###xml 1636 1640 1632 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Hom1">[13]</xref>
###xml 1645 1649 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Han1">[49]</xref>
###xml 1655 1661 1651 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 1726 1731 1722 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAM</italic>
###xml 838 846 <span type="species:ncbi:9606">patients</span>
Migration of leukocytes to sites of inflammation is crucial to the pathogenesis and development of inflammatory lesions in SLE and other autoimmune disorders [44]. Although the mechanisms underlying this leukocyte redistribution are still not fully understood, adhesion molecules such as those of the IgCAM superfamily have been strongly implicated in the recruitment of immune cells to sites of inflammation, and changes in their expression have been reported in rheumatoid arthritis (MIM 180300), multiple sclerosis (MIM 126200), insulin-dependent diabetes mellitus (MIM 222100), and SLE [45], [46]. Increased expression of VCAM-1 and ICAM-1 has been shown in SLE tissues such as the skin [43] and heart [40] and high levels of VCAM-1, associated with enhanced systemic TNF-alpha activity, was recently demonstrated to characterize SLE patients with manifest cardiovascular disease [47]. Given its putative function as an adhesion molecule, MAMDC1 might act through similar mechanisms, and it is possible that genetic alterations of its expression or function might have an impact on SLE disease predisposition and/or manifestations. Remarkably, a similar scenario has been proposed for the new SLE susceptibility gene ITGAM (MIM 120980), recently identified in two parallel GWA studies [12], [13]. It codes for an adhesion molecule interacting, among others, with ICAM-1 to slow down leukocyte rolling and migration to inflammatory sites [48]. Inspired by the functional similarity between MAMDC1 and ITGAM, we performed a preliminary analysis of their potential interaction, by using genotyping data available (unpublished and refs [13] and [49]) for MAMDC1 SNPs rs961616 and rs2297926 (in the entire sample set), and for ITGAM SNPs rs11150614 and rs11574637 (respectively in the UK sample, and in the Finnish and Swedish sample sets). A multivariate logistic regression analysis, however, did not disclose any significant interaction (data not shown).
###end p 39
###begin p 40
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
In conclusion, we have shown here that MAMDC1 polymorphism associates to SLE susceptibility in four sets of patients and controls from Finland, Sweden and the UK. Similar to homologous members of the IgCAM superfamily, the encoded protein has a predicted role in cellular adhesion and migration. While functional polymorphisms are yet to be identified, our data should stimulate further studies to fully appraise the role of MAMDC1 in SLE. Moreover, genetic and/or functional analyses of its interaction(s) with novel SLE predisposing genes might hold potential for the discovery of new pathogenetic pathways.
###end p 40
###begin title 41
Materials and Methods
###end title 41
###begin title 42
Subjects and Samples
###end title 42
###begin title 43
Ethics statement
###end title 43
###begin p 44
Studies on "Identification of genes predisposing for Systemic Lupus Erythematosus (SLE)" has been approved to Professor Juha Kere by the Karolinska Institutet Research Ethics committee South at Huddinge University hospital F59 (Dnr 45/03).
###end p 44
###begin title 45
Finnish sample sets
###end title 45
###begin p 46
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies3">[50]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Brandes1">[37]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
The original Finnish family cohort consist of 192 families (of which 86 were multiply affected by SLE), including 236 individuals affected with SLE and their healthy relatives. All SLE patients included in this cohort were interviewed by the same physician and the case records from the hospitals were reviewed [50]. All patients met the American College of Rheumatology (ACR) criteria for the diagnosis of SLE [37]. A subset of this material, including 35 multiplex families and 31 simplex families, all informative for linkage, was used for the identification and fine mapping of the 14q11.2-q23.2 locus [16], [17].
###end p 46
###begin p 47
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies4">[51]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies4">[51]</xref>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
The Finnish case-control cohort consists of 86 SLE cases and 356 controls from Finland. For the collection of this material, all patients with clinical diagnosis of and SLE attending the Departments of Dermatology at Helsinki and Tampere University Central Hospitals during 1995-2005 were identified from the corresponding hospital registries, and contacted by mail or phone [51]. Unaffected unrelated family members (spouses or common-law spouses) were asked to participate in the study as control individuals, and an existing collection of unrelated individuals was also used as control. The participating patients were clinically examined by doctors working at the Department of Dermatology (SK, TH, JP) and interviewed using a structured questionnaire [51]. The diagnosis of SLE had also been verified by a rheumatologist.
###end p 47
###begin title 48
UK sample set
###end title 48
###begin p 49
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Russell1">[52]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Tan1">[53]</xref>
The UK family cohort consists of 365 SLE parent affected trios and in this collection, diagnosis of SLE was established by telephone interview, health questionnaire and details from clinical notes [52]. All collected probands conformed to the ACR criteria for SLE [53].
###end p 49
###begin title 50
Swedish sample set
###end title 50
###begin p 51
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Svenungsson2">[54]</xref>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
The Swedish case-control cohort consists of 304 cases and 307 controls. All patients were interviewed and examined by a rheumatologist at the Department of Rheumatology, Karolinska University Hospital and all fulfilled four or more of the American College of Rheumatology (ACR) 1982 revised classification criteria for SLE [54]. The control samples were collected from population-based control individuals individually matched for age and sex with the patients.
###end p 51
###begin p 52
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies3">[50]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Russell1">[52]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Svenungsson2">[54]</xref>
###xml 145 153 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008037.s003">Table S3</xref>
###xml 159 171 <span type="species:ncbi:9606">participants</span>
The demographic and clinical characteristics of the study populations have in part been previously described [50]-[52], [54] and are reported in Table S3. All participants included in the present study gave written informed consent for participation in genetic studies on SLE and the study protocols were reviewed and approved by the local ethical committees.
###end p 52
###begin title 53
Genotyping
###end title 53
###begin p 54
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies1">[16]</xref>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Koskenmies2">[17]</xref>
Selection of MS markers has been previously described [16], [17]. The SNPs were selected from dbSNP based on availability and their informativeness as of at the time the study was begun (information regarding tagging properties were limited at the time of SNP selection), with a preference for validated markers with a minor allele frequency (MAF) of >0.2. SNP positions are presented according to their location in the NCBI dbSNP Build 128.
###end p 54
###begin p 55
###xml 423 427 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Jurinke1">[55]</xref>
###xml 504 508 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-OConnell1">[56]</xref>
All genotyping was performed at the Mutation Analysis Facility (MAF) at Karolinska Institutet, Huddinge, Sweden () using the Molecular Dynamics MegaBACE 1000 system (Global Medical Instrumentation, Albertville, MN, USA) for MS genotyping, and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry based on allele-specific primer extension with either MassEXTEND(R) (hME) or iPLEX methods [55] (Sequenom Inc., San Diego, California, USA, ), for SNP genotyping. PedCheck [56] was used to detect Mendelian inconsistencies, and markers deviating >10% than expected were excluded from the analysis. Hardy-Weinberg calculations were performed in controls to ensure that each marker was in equilibrium.
###end p 55
###begin title 56
Northern Blot
###end title 56
###begin p 57
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 554 556 554 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 643 648 <span type="species:ncbi:9606">human</span>
A pCMV6-XL4 vector containing a sequence identical to MAMDC1 NCBI database entry AY369208.1 was purchased from OriGene Technologies (Rockville, MD, USA) and entirely sequenced, identifying an additional 108 bp of 5' untranslated region (UTR) from MAMDC1 exon 1a, and a G to T nucleotide change in exon 9 (corresponding to the SNP rs12590500). The MAMDC1 full-length cDNA was excised from the vector using Not 1 restriction digesion (New England Biolabs, Ipswich, MA, USA) and gel purified. Fifty nano grams (ng) of purified cDNA were then labelled with P32-dCTP (GE Healthcare, Buckinghamshire, UK) by random priming and was used to probe two human multiple tissue polyA+ RNA Northern blots (HB2010 and HB2011, OriGene Technologies) according to manufacturer's instructions. Twenty five ng of beta-Actin cDNA control probe were used for normalization (OriGene Technologies). Exposure to Hyperfilm MP (GE Healthcare) was done for three days.
###end p 57
###begin title 58
Immunohistochemistry
###end title 58
###begin p 59
Formalin-fixed paraffin-embedded tissue sections from testis (n = 2), kidney (n = 1), duodenum (n = 2), placenta (n = 2), cutaneous squamous cell carcinoma (n = 4), and SLE skin (n = 9), were obtained from the Departments of Pathology and Dermatopathology, Helsinki University Central Hospital, Finland. The SLE diagnoses were based on clinical and laboratory data (SK), and confirmed histologically by an experienced dermatopathologist. The use of archived paraffin-embedded material was approved by the corresponding Ethical Review Board of the Helsinki University Central Hospital, Finland.
###end p 59
###begin p 60
###xml 273 279 <span type="species:ncbi:9986">rabbit</span>
###xml 377 383 <span type="species:ncbi:9913">bovine</span>
###xml 466 472 <span type="species:ncbi:9986">Rabbit</span>
IHC analysis was performed using the peroxidase-conjugated EnVision+ peroxidase technique (Dual Link System, Peroxidase, DakoCytomation, Glostrup, Denmark), with diaminobenzidine (DAB) as chromogenic substrate and Mayer hematoxylin as counterstain. Incubation with primary rabbit polyclonal antibody (1:20, HPA003084, Atlas Antibodies, Stockholm, Sweden), in PBS containing 1% bovine serum albumin (BSA, Sigma-Aldrich), was performed for 30 min at room temperature. Rabbit immunoglobulin G serum (1:20, Zymed Laboratories Inc., South San Francisco, CA, USA) or 1% BSA in PBS was used as a negative control.
###end p 60
###begin p 61
Immunohistochemical specimens were analyzed by three different investigators (TMJ, US-K, A R-S) under a light microscope at 200x magnification. Staining of 10 or more cells was interpreted as positive result.
###end p 61
###begin title 62
THP-1 Cell Stimulations
###end title 62
###begin p 63
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
THP-1 monocytes were plated on 6-well-plates (1.4x106 cells/well) and grown overnight in RPMI 1640 medium (GIBCO Invitrogen Life Technologies, Paisley, Scotland) supplemented with 10% FCS, 1 mM sodium pyruvate, 10 mM HEPES, 100 U of penicillin, 100 microg/ml streptomycin and 0.05 mM beta-mercaptoethanol. The cells were then treated with 1microg/ml LPS (Sigma, St. Louis, MO, USA), 10 ng/ml TGF-beta1 (Sigma), 5 U/ml IL-1beta (Roche Molecular Biochemicals, Indiananpolis, IN, USA), 10 ng/ml IFN-gamma (Sigma), 50 ng/ml TNF-alpha (Sigma), or a combination of TNF-alpha and IFN-gamma. Stimulation was allowed to proceed for 6 and 24 h. All experiments were carried out in triplicate and cells grown in normal medium were used as controls.
###end p 63
###begin title 64
Quantitative qRT-PCR
###end title 64
###begin p 65
Total RNA was extracted from lysed cells using the RNeasy Mini-kit (QIAGEN Inc, Hilden, Germany) and reverse transcribed to cDNA using SuperScripttrade mark III Reverse Transcriptase reagents (Invitrogen, Carlsbad, CA, USA), according to manufacturers' instructions.
###end p 65
###begin p 66
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 63 89 63 89 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCTCTGGCCAAGGAGTGT-3&#8242;</named-content>
###xml 100 126 100 126 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCTGAGTGCACAATACGAA-3&#8242;</named-content>
Primers specific to the MAMDC1 full-length isoform 1 (forward: 5'-GATCTCTGGCCAAGGAGTGT-3'; reverse: 5'-GCCTGAGTGCACAATACGAA-3') were designed with the Primer Express 2.0 software (Applied Biosystems, Foster City, CA, USA). Quantitative qRT-PCR reactions, with cDNA as template, were performed in triplicates with the 7500 Fast Real-Time PCR system using SYBR green chemistry and standard protocols (Applied Biosystems).
###end p 66
###begin p 67
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAMDC1</italic>
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
After normalization to the endogenous housekeeping gene GAPDH, MAMDC1 level of expression in each sample was determined by the comparative CT method of relative quantification, and expressed in arbitrary units relative to a randomly chosen reference sample or to unstimulated cells.
###end p 67
###begin title 68
Statistics
###end title 68
###begin p 69
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Toivonen1">[22]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Dudbridge1">[21]</xref>
The disease association was initially mined by Haplotype Pattern Mining (HPM, 50,000 permutations) [22] and Pedigree Disequilibrium test (PDT) [21]. HPM is a method based on discovering recurrent marker patterns and has been shown to be robust and powerful for sparse marker maps. PDT integrates extended families information into the more traditional Transmission Disequilibrium Test.
###end p 69
###begin p 70
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Dudbridge1">[21]</xref>
Single marker association for the fine mapping stage was analyzed using two different methods; PDTPHASE in the family cohorts and COCAPHASE in the case control cohorts [21].
###end p 70
###begin p 71
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Nicodemus1">[57]</xref>
Meta-analysis of the case control and family data was performed using the Kazeem and Farrell [57] fixed effect model implemented in the R package catmap1.5 []. Heterogeneity was assessed using a standard Q- test.
###end p 71
###begin p 72
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Nyholt1">[58]</xref>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To take into account multiple testing in the fine mapping step, the nominal significance threshold of P = 0.05 was corrected by finding the number of independent SNPs, using a Principal Component Analysis of the SNPs correlation matrix [58]. Out of the 24 markers genotyped in this study, 16 resulted to be statistically independent, which fixed the significance threshold to P = 0.0032.
###end p 72
###begin p 73
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008037-Barrett1">[59]</xref>
Haplotypes were tested using "haplo.stats 1.3.0" software from R. Here, haplotype inference is performed with a standard Expectation Maximization method and the association is tested with a Generalized Linear Model, which uses haplotypes posterior probabilities as weights. Haplotypes were tested over blocks of consecutive markers as defined in Haploview 4.1 () [59].
###end p 73
###begin title 74
Web Resources
###end title 74
###begin p 75
NCBI ()
###end p 75
###begin p 76
dbSNP ()
###end p 76
###begin p 77
###xml 32 35 <span type="species:ncbi:9606">Man</span>
Online Mendelian Inheritance in Man (OMIM) ()
###end p 77
###begin p 78
Primer3 ()
###end p 78
###begin p 79
SignalP 3.0 ()
###end p 79
###begin p 80
###xml 8 13 <span type="species:ncbi:9606">Human</span>
Swedish Human Protein Atlas program ()
###end p 80
###begin p 81
Mutation Analysis Facility (MAF) at Karolinska Institutet, Stockholm, Sweden ()
###end p 81
###begin p 82
Sequenom Inc. ()
###end p 82
###begin p 83
Haploview 4.1 ()
###end p 83
###begin p 84
R ()
###end p 84
###begin p 85
ClustalW2 ()
###end p 85
###begin title 86
Supporting Information
###end title 86
###begin p 87
Markers genotyped in the study
###end p 87
###begin p 88
(0.14 MB DOC)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
P-values and ORs for the combined analysis
###end p 90
###begin p 91
(0.05 MB DOC)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
Demographic and clinical characteristics of the study populations, as defined by the revised ACR criteria for SLE
###end p 93
###begin p 94
(0.04 MB DOC)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
We thank Anna-Elina Lehesjoki and Albert de la Chapelle for providing DNA from Finnish control individuals. The excellent technical assistance of Alli Tallqvist is also acknowledged.
###end p 96
###begin title 97
References
###end title 97
###begin article-title 98
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.
###end article-title 98
###begin article-title 99
A revised estimate of twin concordance in systemic lupus erythematosus.
###end article-title 99
###begin article-title 100
Infection, vaccines and other environmental triggers of autoimmunity.
###end article-title 100
###begin article-title 101
The application of genetic epidemiology to systemic lupus erythematosus.
###end article-title 101
###begin article-title 102
###xml 10 15 <span type="species:ncbi:9606">human</span>
Update on human systemic lupus erythematosus genetics.
###end article-title 102
###begin article-title 103
Unraveling the genetics of systemic lupus erythematosus.
###end article-title 103
###begin article-title 104
The genetics of SLE: an update in the light of genome-wide association studies.
###end article-title 104
###begin article-title 105
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies.
###end article-title 105
###begin article-title 106
Recent insights into the genetic basis of systemic lupus erythematosus.
###end article-title 106
###begin article-title 107
The genetic contribution to systemic lupus erythematosus.
###end article-title 107
###begin article-title 108
Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis.
###end article-title 108
###begin article-title 109
###xml 32 37 <span type="species:ncbi:9606">women</span>
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
###end article-title 109
###begin article-title 110
Association of Systemic Lupus Erythematosus with C8orf13-BLK and ITGAM-ITGAX.
###end article-title 110
###begin article-title 111
Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus.
###end article-title 111
###begin article-title 112
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
###end article-title 112
###begin article-title 113
Linkage mapping of systemic lupus erythematosus (SLE) in Finnish families multiply affected by SLE.
###end article-title 113
###begin article-title 114
Haplotype associations define target regions for susceptibility loci in systemic lupus erythematosus.
###end article-title 114
###begin article-title 115
###xml 49 54 <span type="species:ncbi:9606">human</span>
A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families.
###end article-title 115
###begin article-title 116
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families.
###end article-title 116
###begin article-title 117
Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence.
###end article-title 117
###begin article-title 118
Pedigree disequilibrium tests for multilocus haplotypes.
###end article-title 118
###begin article-title 119
Data mining applied to linkage disequilibrium mapping.
###end article-title 119
###begin article-title 120
InterProScan-an integration platform for the signature-recognition methods in InterPro.
###end article-title 120
###begin article-title 121
Prediction of potential GPI-modification sites in proprotein sequences.
###end article-title 121
###begin article-title 122
Improved prediction of signal peptides: SignalP 3.0.
###end article-title 122
###begin article-title 123
###xml 35 40 <span type="species:ncbi:9606">human</span>
Characterization of MDGA1, a novel human glycosylphosphatidylinositol-anchored protein localized in lipid rafts.
###end article-title 123
###begin article-title 124
###xml 83 88 <span type="species:ncbi:9606">human</span>
Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors.
###end article-title 124
###begin article-title 125
Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization.
###end article-title 125
###begin article-title 126
Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance.
###end article-title 126
###begin article-title 127
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.
###end article-title 127
###begin article-title 128
Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.
###end article-title 128
###begin article-title 129
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.
###end article-title 129
###begin article-title 130
Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.
###end article-title 130
###begin article-title 131
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
###end article-title 131
###begin article-title 132
Follow-up association study of novel neuroticism gene MAMDC1.
###end article-title 132
###begin article-title 133
###xml 86 92 <span type="species:ncbi:9606">people</span>
Influence of extraversion and neuroticism on subjective well-being: happy and unhappy people.
###end article-title 133
###begin article-title 134
Personality and anxiety disorders.
###end article-title 134
###begin article-title 135
Personality and psychopathology: an application of the five-factor model.
###end article-title 135
###begin article-title 136
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes.
###end article-title 136
###begin article-title 137
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus.
###end article-title 137
###begin article-title 138
###xml 103 107 <span type="species:ncbi:10090">mice</span>
TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice.
###end article-title 138
###begin article-title 139
###xml 139 144 <span type="species:ncbi:9606">human</span>
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells.
###end article-title 139
###begin article-title 140
Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited.
###end article-title 140
###begin article-title 141
Mechanisms of lymphocyte migration in autoimmune disease.
###end article-title 141
###begin article-title 142
Adhesion molecules in autoimmune disease.
###end article-title 142
###begin article-title 143
Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases.
###end article-title 143
###begin article-title 144
Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
###end article-title 144
###begin article-title 145
Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation.
###end article-title 145
###begin article-title 146
Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE).
###end article-title 146
###begin article-title 147
Familial systemic lupus erythematosus in Finland.
###end article-title 147
###begin article-title 148
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.
###end article-title 148
###begin article-title 149
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.
###end article-title 149
###begin article-title 150
The 1982 revised criteria for the classification of systemic lupus erythematosus.
###end article-title 150
###begin article-title 151
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
###end article-title 151
###begin article-title 152
Automated genotyping using the DNA MassArray technology.
###end article-title 152
###begin article-title 153
PedCheck: a program for identification of genotype incompatibilities in linkage analysis.
###end article-title 153
###begin article-title 154
Catmap: case-control and TDT meta-analysis package.
###end article-title 154
###begin article-title 155
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.
###end article-title 155
###begin article-title 156
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 156
###begin article-title 157
Multiple sequence alignment with the Clustal series of programs.
###end article-title 157
###begin p 158
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 158
###begin p 159
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the Academy of Finland, Sigrid Juselius Foundation and Finska Lakarsallskapet, Finland and Swedish Research Council (to JK and US-K), the Helsinki University Central Hospital Research Fund (TYH5241), the Welander-Finsen Foundation, Sweden (to TS), the Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine (to TMJ), and by personal grants from the University of Helsinki Research Foundation and the Biomedicum Helsinki Foundation (TMJ). Further support came from the Swedish Heart-Lung Foundation, The Royal Physiographic Society in Lund, The King Gustaf V 80th Birthday Fund, The Ake Wiberg Foundation and ALF funding from Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 159

